Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of alfentanil and remifentanil on QT interval during septoplasty
IRCT2014020816524N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of alfentanil and remifentanil in long QT syndrome (LQTS) (2 arms), sponsored by Shiraz University of Medical Sciences. Started May 2014; status: completed.
02
Drugs
alfentanilremifentanil
03
Conditions
long QT syndrome (LQTS)
Beyond the preview
Go deeper on IRCT2014020816524N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014020816524N1.